{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:13:40Z","timestamp":1791515620737,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007710","name":"University of Connecticut","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncolytics"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.omto.2021.01.004","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T02:56:24Z","timestamp":1610938584000},"page":"265-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Structure-based virtual screening identifies an 8-hydroxyquinoline as a small molecule GLI1 inhibitor"],"prefix":"10.1016","volume":"20","author":[{"given":"Radha Charan","family":"Dash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Zaino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shana R.","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne Q.","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Wechsler-Reya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Kyle","family":"Hadden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omto.2021.01.004_bib1","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/cancers11040538","article-title":"Next-generation hedgehog\/GLI pathway inhibitors for cancer therapy","volume":"11","author":"Peer","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omto.2021.01.004_bib2","doi-asserted-by":"crossref","first-page":"15773","DOI":"10.1038\/ncomms15773","article-title":"EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells","volume":"8","author":"Neelakantan","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omto.2021.01.004_bib3","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.7150\/jca.15786","article-title":"Hedgehog signaling non-canonical activated by pro-inflammatory cytokines in pancreatic ductal adenocarcinoma","volume":"7","author":"Wang","year":"2016","journal-title":"J.\u00a0Cancer"},{"key":"10.1016\/j.omto.2021.01.004_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1101\/gad.1753809","article-title":"GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation","volume":"23","author":"Nolan-Stevaux","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.omto.2021.01.004_bib5","doi-asserted-by":"crossref","first-page":"11786","DOI":"10.1074\/jbc.M112.438846","article-title":"Loss of the transcription factor GLI1 identifies a signaling network in the tumor microenvironment mediating KRAS oncogene-induced transformation","volume":"288","author":"Mills","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omto.2021.01.004_bib6","doi-asserted-by":"crossref","first-page":"25749","DOI":"10.1074\/jbc.M116.753129","article-title":"Gli transcription factors mediate the oncogenic transformation of prostate basal cells induced by a Kras-androgen receptor axis","volume":"291","author":"Wu","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omto.2021.01.004_bib7","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3892\/or.2013.2534","article-title":"Role of GLI-1 in epidermal growth factor-induced invasiveness of ARCaPE prostate cancer cells","volume":"30","author":"Zhu","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.omto.2021.01.004_bib8","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1158\/0008-5472.CAN-16-3315","article-title":"GLI1 blockade potentiates the antitumor activity of PI3K antagonists in lung squamous cell carcinoma","volume":"77","author":"Kasiri","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2021.01.004_bib9","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1038\/onc.2017.91","article-title":"Noncanonical GLI1 signaling promotes stemness features and in\u00a0vivo growth in lung adenocarcinoma","volume":"36","author":"Po","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.omto.2021.01.004_bib10","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1158\/1078-0432.CCR-13-2195","article-title":"Hedgehog-GLI signaling inhibition suppresses tumor growth in squamous lung cancer","volume":"20","author":"Huang","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2021.01.004_bib11","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1158\/0008-5472.CAN-10-2315","article-title":"Hedgehog signaling drives cellular survival in human colon carcinoma cells","volume":"71","author":"Mazumdar","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2021.01.004_bib12","doi-asserted-by":"crossref","first-page":"80190","DOI":"10.18632\/oncotarget.13376","article-title":"Targeting GLI by GANT61 involves mechanisms dependent on inhibition of both transcription and DNA licensing","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.omto.2021.01.004_bib13","doi-asserted-by":"crossref","first-page":"638","DOI":"10.18632\/oncotarget.310","article-title":"The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer","volume":"2","author":"Mazumdar","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.omto.2021.01.004_bib14","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3389\/fgene.2019.00556","article-title":"Non-canonical hedgehog signaling pathway in cancer: Activation of GLI transcription factors beyond smoothened","volume":"10","author":"Pietrobono","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.omto.2021.01.004_bib15","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.0609699104","article-title":"Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists","volume":"104","author":"Lauth","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omto.2021.01.004_bib16","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.18632\/oncotarget.2046","article-title":"Mode and specificity of binding of the small molecule GANT61 to GLI determines inhibition of GLI-DNA binding","volume":"5","author":"Agyeman","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.omto.2021.01.004_bib17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.15252\/embj.201489213","article-title":"Gli1\/DNA interaction is a druggable target for Hedgehog-dependent tumors","volume":"34","author":"Infante","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.omto.2021.01.004_bib18","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1021\/acsmedchemlett.9b00639","article-title":"Pharmacophore-Based Virtual Screening for Identification of Negative Modulators of GLI1 as Potential Anticancer Agents","volume":"11","author":"Manetti","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.omto.2021.01.004_bib19","article-title":"Gli1 inhibitors and uses thereof","author":"Giannini","year":"2017","journal-title":"European patent EP3388419A1, filed"},{"key":"10.1016\/j.omto.2021.01.004_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/14756366.2017.1419221","article-title":"Chemical, computational and functional insights into the chemical stability of the Hedgehog pathway inhibitor GANT61","volume":"33","author":"Calcaterra","year":"2018","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.omto.2021.01.004_bib21","series-title":"Multitarget Hedgehog pathway inhibitors and uses thereof. (Sapienza Universit\u00e0 di Roma)","author":"Botta","year":"2013"},{"key":"10.1016\/j.omto.2021.01.004_bib22","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1126\/science.8378770","article-title":"Crystal structure of a five-finger GLI-DNA complex: new perspectives on zinc fingers","volume":"261","author":"Pavletich","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.omto.2021.01.004_bib23","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.bmcl.2011.12.081","article-title":"Evaluation of vitamin D3 A-ring analogues as Hedgehog pathway inhibitors","volume":"22","author":"Banerjee","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.omto.2021.01.004_bib24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejmech.2015.01.049","article-title":"Vitamin D3 analogues that contain modified A- and seco-B-rings as hedgehog pathway inhibitors","volume":"93","author":"DeBerardinis","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.omto.2021.01.004_bib25","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.bmcl.2016.11.019","article-title":"A matrix-focused structure-activity and binding site flexibility study of quinolinol inhibitors of botulinum neurotoxin serotype A","volume":"27","author":"Harrell","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.omto.2021.01.004_bib26","article-title":"Enantiomers Of 8-hydroxy Quinoline Derivatives And The Synthesis Thereof","author":"Pusk\u00e1s","year":"2016","journal-title":"WO 2016\/162706 A1, 2016\/03\/07"},{"key":"10.1016\/j.omto.2021.01.004_bib27","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.3390\/molecules23081934","article-title":"Synthesis and cytoprotective characterization of 8-hydroxyquinoline Betti products","volume":"23","author":"Kanizsai","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.omto.2021.01.004_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccr.2008.07.003","article-title":"Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells","volume":"14","author":"Yang","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omto.2021.01.004_bib29","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1158\/0008-5472.CAN-12-4258","article-title":"Targeting sonic hedgehog-associated medulloblastoma through inhibition of Aurora and Polo-like kinases","volume":"73","author":"Markant","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2021.01.004_bib30","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1038\/onc.2014.304","article-title":"Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma","volume":"34","author":"Brun","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.omto.2021.01.004_bib31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nmeth.4346","article-title":"Points of Significance: Principal component analysis","volume":"14","author":"Lever","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omto.2021.01.004_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-62703-658-0_11","article-title":"Principal component analysis: a method for determining the essential dynamics of proteins","volume":"1084","author":"David","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omto.2021.01.004_bib33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1158\/0008-5472.CAN-10-2876","article-title":"Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance","volume":"71","author":"Dijkgraaf","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2021.01.004_bib34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ccell.2015.02.001","article-title":"Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma","volume":"27","author":"Sharpe","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omto.2021.01.004_bib35","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ccell.2015.02.002","article-title":"Smoothened variants explain the majority of drug resistance in basal cell carcinoma","volume":"27","author":"Atwood","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omto.2021.01.004_bib36","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/308509a0","article-title":"The locus of sequence-directed and protein-induced DNA bending","volume":"308","author":"Wu","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.omto.2021.01.004_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/bies.950150105","article-title":"Bending of DNA by transcription factors","volume":"15","author":"van der Vliet","year":"1993","journal-title":"BioEssays"}],"container-title":["Molecular Therapy Oncolytics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770521000048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770521000048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:31:40Z","timestamp":1784723500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2372770521000048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":37,"alternative-id":["S2372770521000048"],"URL":"https:\/\/doi.org\/10.1016\/j.omto.2021.01.004","relation":{},"ISSN":["2372-7705"],"issn-type":[{"value":"2372-7705","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-based virtual screening identifies an 8-hydroxyquinoline as a small molecule GLI1 inhibitor","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncolytics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omto.2021.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}]}}